Technical References ( EpiGingival )
715. NUCLEOTIDE EXCISION REPAIR IS REDUCED IN ORAL EPITHELIAL TISSUES COMPARED WITH SKIN.
Mitchell1, D., Paniker1, L. and Godar2, D. 1Department of Carcinogenesis, University of Texas, MD Anderson Cancer Center, Smithville, TX. 2US Food and Drug Administration, Center for Devices and Radiological Health, Silver Spring, MD. Photochem. and Photobio., 88, 1027–1032, (2012).
683. UPDATE ON VALIDATION STATUS AND INDUSTRY UTILIZATION OF NORMAL HUMAN 3D (NHU-3D) ANIMAL ALTERNATIVE MODELS.
Kandarova, H., Klausner, M., Kubilus, J., Ayehunie, S., Hayden, P., Kaluzhny, Y., Letasiova, S., and Sheasgreen, J. MatTek Corporation, Ashland, MA, USA and MatTek In Vitro Life Science Laboratories, Bratislava, Slovakia. Presented at 8th World Congress on Alternative and Animal Use, Montreal, Canada, 2011.
672. RETENTION OF O-CYMEN-5-OL AND ZINC ON RECONSTRUCTED HUMAN GINGIVAL TISSUE FROM A TOOTHPASTE FORMULATION.
Yang, J., Deol, G. and Myangar, N. GlaxoSmithKline Consumer Healthcare, Weybridge, UK. Inter. Dental Journal, 61 (Suppl. 3): 41-45, 2011.
450. METHODS FOR ASSESSMENT OF PROLIFERATION IN AN IN VITRO TISSUE MODEL OF ORAL EPITHELIA.
Ackerman, G.L., Chlipata, E. Premier Laboratory, LLC, University of Colorado, Boulder, CO. Histologic, Vol. 38, No. 1, May 2005.
439. INFECTION OF HUMAN CYTOMEGALOVIRUS IN CULTURED HUMAN GINGIVAL TISSUE.
Hai, R., Chu, A., Li, H., Umamoto, S., Rider, P., and Liu, F. Program in Infectious Diseases and Immunity, Program in Comparative Biochemistry, School of Public Health, 140 Warren Hall, University of California, Berkeley, CA 94720, USA. Virology Journal, 3:84, (2006).
438. ORGANOTYPIC HUMAN ORAL TISSUE MODELS FOR TOXICOLOGICAL STUDIES.
Klausner1, M., Ayehunie1, S., Breyfogle1, B.A., Wertz2, P.W., Bacca3, L., Kubilus1, J. 1MatTek Corporation, Ashland, MA 01721, United States, 2University of Iowa, Iowa City, IA 52242, United States, 3Procter and Gamble Company, Mason, OH 45040, United States. Toxicology in Vitro, 21, 938-949 (2007).
399. CHARACTERIZATION AND TESTING OF NEW BUCCAL AND GINGIVAL TISSUE MODELS.
Kubilus1, J., Ayehunie1, S., Breyfogle1, B., Dale2, B., Kimball2, J., Wertz3, P., Klausner1, M. 1MatTek Corporation, Ashland, MA, USA; 2University of Washington, Seattle, USA; 3University of Iowa, Iowa City, USA. Poster presented at American Association for Dental Research and American Dental Education Association annual meeting, Orlando, FL, March 8-11 (2006).
395. BENZO[A]PYRENE-INDUCED ORAL CARCINOGENESIS AND CHEMOPREVENTION – STUDIES IN BIOENGINEERED HUMAN TISSUE.
Walle1, T., Walle1, U.K., Sedmera2, D., Klausner3, M. 1Department of Cell and Molecular Pharmacology and Experimental Therapeutics, University of South Carolina, Charleston; 2Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston; 3MatTek Corporation, Ashland, Massachusetts. Drug Metabolism and Disposition, 2006 34: 346-350.
379. EPIGINGIVAL™ (GIN-100) TISSUE MODELS FOR ORAL IRRITATION STUDIES.
Breyfogle1,B., Kubilus1, J., Dale2, B., Wertz3, P. 1MatTek Corporation, Ashland, MA, USA, 2University of Washington, Seattle, WA, USA, 3University of Iowa, Iowa City, IA, USA. Presented at 5th World Congress, Berlin, Germany, August, (2005).
325. CHARACTERIZATION OF NEW BUCCAL AND GINGIVAL EPITHELIAL TISSUE MODELS.
Kubilus1, J., Breyfogle1, B., Sheasgreen1, J., Hayden1, P., and Wertz2, P., Dale3, B., Kimball3, J., and Klausner1, M. 1MatTek Corporation, Ashland, MA, 2University of Iowa, Iowa City, IA, 3University of Washington, Seattle, WA. J. Invest. Dermatol., 122, (3), A79, Abstract #474, (2004).
263. GINGIVAL TISSUE MODEL FOR PREDICTION OF IRRITANCY OF ORAL CARE PRODUCTS.
Kubilus, J., Klausner, M., Breyfogle, B. MatTek Corporation, Ashland, MA. Presented at Soc. Invest. Derm. Meeting, May (2002).
